# Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke

> **NCT07730840** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Asan Medical Center** · enrollment: 984 (estimated)

## Conditions studied

- Ischemic Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Zastaprazan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07730840
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-15
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 984 (ESTIMATED)
- **Last updated:** 2026-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07730840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07730840, "Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07730840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*